RxDoctor Payments Data

Natalee Kontir, DO

Family Medicine · Homer City, PANPI 1770779761

Payments from drug & device makers

$272in general payments, 2019–2025

Across 17 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$96
  • AstraZeneca$33
  • Lilly USA, LLC$31
  • Boehringer Ingelheim$29
  • Bayer$29
  • AbbVie$24
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$272 in reported general payments places this provider in the 50th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$848
Medicare patients
14
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide71$67,686
MounjaroTirzepatide63$65,411
JardianceEmpagliflozin76$57,803
OzempicSemaglutide46$51,658
FarxigaDapagliflozin Propanediol61$41,799
RybelsusSemaglutide24$30,455
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$30,139
SynjardyEmpagliflozin/Metformin Hcl19$20,064
TradjentaLinagliptin36$19,655
EliquisApixaban19$15,085
Victoza 3-PakLiraglutide11$10,915
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$7,712
Lantus SolostarInsulin Glargine,hum.Rec.Anlog64$6,716
Tresiba Flextouch U-100Insulin Degludec14$6,480
Albuterol Sulfate HfaAlbuterol Sulfate195$6,226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$31$133,098134 claims
Boehringer IngelheimJardiance, Synjardy, Tradjenta$29$97,521131 claims
Novo NordiskOzempic, Rybelsus$96$82,11270 claims
AstraZenecaFarxiga, Symbicort$33$44,42972 claims
PfizerEliquis$15$15,08519 claims
AbbVieSynthroid$24$78122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Homer City

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →